Results 191 to 200 of about 51,359 (234)

Identification and validation of biomarkers related to mitochondria-associated endoplasmic reticulum membranes in type 2 diabetes mellitus using peripheral blood transcriptomics. [PDF]

Eur J Med Res
Li S, Yan Y, Luo Q, Tian R, Yan J.
europepmc   +1 more source

Pioglitazone Represents an Effective Therapeutic Target in Preventing Oxidative/Inflammatory Cochlear Damage Induced by Noise Exposure

, 2018
Fabiola Paciello, Anna Rita Fetoni, Rolando Rolesi, Matthew B. Wright, Claudio Grassi, Diana Troiani, Gaetano Paludetti   +6 more
openalex   +1 more source

Reversing Alcohol-Dependent Effects on HIV Replication: Are There Roles for Pioglitazone and N-acetylcysteine? [PDF]

Am J Respir Cell Mol Biol
Manicone AM, Brune JE.
europepmc   +1 more source

Targeting adipose remodeling: Synergistic mechanisms of drugs and adipose-derived stem cells in obese type 2 diabetes mellitus. [PDF]

World J Stem Cells
Luo C, Yu XM, Hua LY, Zeng MQ, Xu H, Duan CZ, Xu SY, Sun D, Ye LY, He DJ.   +9 more
europepmc   +1 more source

Pioglitazone inhibits the expression of matrix metalloproteinase-9, a protein involved in diabetes-associated wound healing

, 2014
Jun Zhang, Xiaoyuan Huang, Lingfeng Wang
openalex   +2 more sources

Lipid Storage and Therapy Resistance in Chronic Myeloid Leukaemia: A Novel Perspective on Targeting Metabolic Vulnerabilities. [PDF]

Cancers (Basel)
Tolland M, Ross DM, White D, Hughes TP, Pagani IS.   +4 more
europepmc   +1 more source

Peroxisome Proliferator-Activated Receptor α/δ/γ Activation Profile by Endogenous Long-Chain Fatty Acids. [PDF]

Int J Mol Sci
Honda A, Hosoda A, Kamichatani W, Ogasawara M, Miyazaki S, Kashiwagi N, Kamata S, Ishii I.   +7 more
europepmc   +1 more source

HDM and mannose as novel tolerogenic inducers for dendritic cells: mTOR/PPARγ-mediated attenuation of allergic asthma. [PDF]

Eur J Med Res
Wang F, Min Z, Gao J, Qian Y, Jiang Z, Gao X, Chen Z.   +6 more
europepmc   +1 more source

Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trial. [PDF]

Diabetes Obes Metab
Cho YK, Cho JH, Hong SM, Park JH, Lee BW, Yoo JH, Kim JH, Chun SW, Hwang YC, Song KH, Lee WJ.   +10 more
europepmc   +1 more source

Ineffectiveness of pioglitazone in cognitive impairment induced by cyclophosphamide, methotrexate, and fluorouracil via oxidative stress and neuroinflammation. [PDF]

Front Neurosci
Alhowail AH.
europepmc   +1 more source